Related Experiment Video
Updated: Feb 1, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1
Wei Cao1, Le Fang2, Siyong Teng3
1Clinical Laboratory, Beijing Rehabilitation Hospital of Capital Medical University, Beijing 100041, P.R. China.
Abstract:
Emerging pieces of evidence indicate that microRNA-466 (miR-466) serves as a tumor suppressor in several human tumors, including colorectal cancer and prostate cancer. However, whether miR-466 is involved in osteosarcoma (OS) progression remains largely unknown. The present study demonstrated that miR-466 was significantly downregulated in OS tissues and cell lines. Furthermore, it was revealed that the expression of miR-466 was negatively correlated with OS severity. Moreover, low miR-466 expression in patients with OS predicted poor prognosis. Through functional experiments, miR-466 overexpression significantly inhibited the proliferation and cell cycle of OS cells while inducing cellular apoptosis. In terms of mechanism, it was revealed that CCND1 was a target of miR-466 in OS cells. miR-466 overexpression suppressed CCND1 expression in OS cells. A reverse association was observed between the expression levels of miR-466 and CCND1 in OS tissues. Furthermore, CCND1 restoration in OS cells significantly rescued the effects of miR-466 on cellular proliferation and apoptosis. Overall, the results of the present study demonstrated that miR-466 suppressed OS progression by targeting CCND1, suggesting that miR-466 may be a promising biomarker and therapeutic target for OS prognosis and treatment.
Insights
MicroRNA-466 (miR-466) acts as a tumor suppressor in osteosarcoma (OS) by inhibiting cancer cell growth and promoting apoptosis. Downregulation of miR-466 predicts poor prognosis, highlighting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-466 (miR-466) is recognized as a tumor suppressor in various cancers.
- Its role in osteosarcoma (OS) progression is not well-established.
Purpose of the Study:
- To investigate the function and mechanism of miR-466 in osteosarcoma.
- To determine if miR-466 can serve as a prognostic biomarker for OS.
Main Methods:
- Quantitative real-time PCR to assess miR-466 expression in OS tissues and cell lines.
- Functional assays (proliferation, cell cycle, apoptosis) to evaluate miR-466's impact on OS cells.
- Western blot and luciferase reporter assays to identify and validate miR-466 targets.
Main Results:
- miR-466 expression was significantly downregulated in OS tissues and cell lines, correlating negatively with OS severity.
- Low miR-466 expression predicted poor prognosis in OS patients.
- Overexpression of miR-466 inhibited OS cell proliferation and cell cycle progression while inducing apoptosis.
- CCND1 was identified as a direct target of miR-466, and its restoration rescued the anti-tumor effects of miR-466.
Conclusions:
- miR-466 suppresses osteosarcoma progression by targeting CCND1.
- miR-466 holds potential as a promising biomarker and therapeutic target for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Apoptosis
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation

